APHKX
Price
$47.45
Change
-$0.80 (-1.66%)
Updated
Dec 18 closing price
BRZKX
Price
$10.99
Change
-$0.27 (-2.40%)
Updated
Dec 18 closing price
Ad is loading...

APHKX vs BRZKX

Header iconAPHKX vs BRZKX Comparison
Open Charts APHKX vs BRZKXBanner chart's image
Artisan International Value Instl
Price$47.45
Change-$0.80 (-1.66%)
VolumeN/A
CapitalizationN/A
BlackRock Sus Adg Intl Eq K
Price$10.99
Change-$0.27 (-2.40%)
VolumeN/A
CapitalizationN/A
APHKX vs BRZKX Comparison Chart
Loading...
View a ticker or compare two or three
VS
APHKX vs. BRZKX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APHKX is a Hold and BRZKX is a Hold.

FUNDAMENTALS
Fundamentals
APHKX has more cash in the bank: 35.3B vs. BRZKX (11.7M). BRZKX pays higher dividends than APHKX: BRZKX (2.48) vs APHKX (1.21). APHKX was incepted earlier than BRZKX: APHKX (18 years) vs BRZKX (4 years). BRZKX is a more actively managed with annual turnover of: 118.00 vs. APHKX (19.48). APHKX has a lower initial minimum investment than BRZKX: APHKX (1000000) vs BRZKX (5000000). BRZKX annual gain was more profitable for investors over the last year : 10.49 vs. APHKX (8.60).
APHKXBRZKXAPHKX / BRZKX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence18 years4 years-
Gain YTD6.0037.83377%
Front LoadN/AN/A-
Min. Initial Investment1000000500000020%
Min. Initial Investment IRAN/AN/A-
Net Assets35.3B11.7M301,709%
Annual Yield % from dividends1.212.4849%
Returns for 1 year8.6010.4982%
Returns for 3 years21.2514.73144%
Returns for 5 years38.66N/A-
Returns for 10 years57.60N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NTIC14.32-0.10
-0.69%
Northern Technologies International Corp
ITT149.06-2.64
-1.74%
ITT
TRTX8.85-0.20
-2.21%
TPG RE Finance Trust
HBM8.36-0.22
-2.56%
Hudbay Minerals
SONN1.72-0.09
-4.97%
Sonnet BioTherapeutics Holdings Inc